. 2024 May 29;84(6):529–540. doi: 10.1055/a-2300-5326
The Author(s). This is an open access article published by
Thieme under the terms of the Creative Commons
Attribution-NonDerivative-NonCommercial License, permitting copying and
reproduction so long as the original work is given appropriate credit. Contents
may not be used for commecial purposes, or adapted, remixed, transformed or
built upon. (
https://creativecommons.org/licenses/by-nc-nd/4.0/
)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
Abb. 1.
Therapiealgorithmus für Patientinnen mit fortgeschrittenem HRpos/HER2neg Mammakarzinom 25 .